Aim The aim of this study was to determine possible long-term effects of multi-injections of
botulinum toxin A (BT-A) on muscle tone and functional abilities in children with cerebral …

The long‐term effects of botulinum toxin A (BoNT‐A) treatment in children with cerebral
palsy (CP) are still elusive. We studied a prospective clinical cohort of 94 children with …

Objective: To determine if very low doses of botulinum toxin type A (BTX-A) could reduce
spasticity and improve gait in cerebral palsied children when combined with rehabilitation …

Botulinum toxin A is widely used for spasticity management in children with cerebral palsy,
although outcomes are unpredictable. The aim of this study was to identify criteria for …

Objective: Botulinum toxin A inhibits presynaptic release of acetylcholine at the
neuromuscular junction and has reportedly been successful in the treatment of spastic …

Botulinum A toxin produces selective and reversible chemodenervation that can be
employed to balance muscle forces across joints in children with cerebral palsy (CP) …

Objective: To evaluate whether botulinum toxin type A injections improve upper limb function
in children with cerebral palsy. Methods: An extensive search was carried out in PUBMED …

At least two randomized controlled trials (RCTs) have shown botulinum toxin type A (BtxA) to
be efficacious and safe when used in the management of muscle spasticity in children …

Background. Rehabilitation of the upper extremity in children with hemiplegic cerebral palsy
has not been compared to the same intensity of therapy combined with injected botulinum …

Botulinum toxin type A (BTX‐A) has been used successfully to manage spasticity in children
with cerebral palsy. Little has been done to evaluate treatment outcome and satisfaction …